AI Article Synopsis

  • The study looked at how the beta-agonist cimaterol affects growth and body composition in neonatal rats of different sizes.
  • Administration of cimaterol led to a more significant body weight loss in larger rats, showing a dose-dependent decline in growth for both strains.
  • While cimaterol didn’t change body fat or protein levels, it reduced muscle growth and increased heart size, indicating that the effects of beta-agonists can vary based on the genotype of the animal.

Article Abstract

The effect of subcutaneous injection of the beta-agonist cimaterol on growth and body composition of neonatal rats differing in growth potential was examined. Rats that represented substrain populations of Charles River CD rats selected for either large or small body size were used. Cimaterol administration resulted in a greater reduction in body weight gain in the Large strain rats. Body growth rate declined linearly with increasing doses of cimaterol in both strains. Percent carcass fat and protein were unchanged with cimaterol treatment. Administration of cimaterol inhibited skeletal muscle growth but caused cardiac hypertrophy. These results suggest that the effectiveness of beta-agonists is influenced by animal genotype.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000242904DOI Listing

Publication Analysis

Top Keywords

beta-agonist cimaterol
8
cimaterol growth
8
composition neonatal
8
neonatal rats
8
rats selected
8
selected large
8
large small
8
small body
8
body size
8
growth
5

Similar Publications

The addition of -agonists to animal feed can significantly improve the lean-meat rate of pigs, cattle, sheep, and other animals. However, the food residues of -agonists are harmful to human health. When meat with -agonist residues is consumed, poisoning symptoms such as palpitation, dizziness, and muscle tremors may develop, and damage to the cardiovascular system, liver, and kidney may occur.

View Article and Find Full Text PDF

Beta-agonist drugs modulate the proliferation and differentiation of skeletal muscle cells .

Biochem Biophys Rep

July 2021

Department of Life Sciences, College of Biosciences and Biotechnology, National Cheng Kung University, Tainan City, 701, Taiwan, ROC.

Essentially employed for the treatment of airway obstructions in humans, β-agonists are also known to have an anabolic effect in animals' skeletal muscle. and studies have attested the increase in animal body mass and the hypertrophy of muscle cells following the administration of specific β-agonists. However, the contribution of β-agonists to C2C12 myoblasts growth remains obscure.

View Article and Find Full Text PDF

A paper-based competitive lateral flow immunoassay for multi β-agonist residues by using a single monoclonal antibody labelled with red fluorescent nanoparticles.

Mikrochim Acta

January 2019

1Key Laboratory of Agro-product Safety and Quality, Ministry of Agriculture, Beijing, 100081 People's Republic of China.

An ultrasensitive paper based lateral flow assay is described for rapid and simultaneous fluorometric detection of several β-agonists including clenbuterol and its chemical analogues (mabuterol, brombuterol, cimaterol, cimbuterol, bromchlorbuterol and banbuterol). A nonspecific monoclonal antibody (mAb) against clenbuterol and its analogues was prepared and employed in a competitive immunoassay where mAb conjugated to fluorescent nanoparticles and free β-agonists compete for the binding sites. This enables rapid screening for the 7 β-agonists in a single run that takes about 8 min.

View Article and Find Full Text PDF

Broad screening and identification of β-agonists in feed, serum, urine, muscle and liver samples was achieved in a quick and highly sensitive manner using ultra high performance liquid chromatography-quadrupole-orbitrap high resolution mass spectrometry (UHPLC-Q-Orbitrap HRMS) combined with a spectra library search. Solid-phase extraction technology was employed for sample purification and enrichment. After extraction and purification, the samples were analyzed using a Q-Orbitrap high-resolution mass spectrometer under full-scan and data-dependent MS/MS mode.

View Article and Find Full Text PDF

Growth hormone (GH) and β agonists increase muscle mass, but the mechanisms for this response are unclear and the magnitude of response is thought to vary with age of animal. To investigate the mechanisms driving the muscle response to these agents, we examined the effects of short-term (6 day) administration of GH or cimaterol (a β2-adrenergic agonist, BA) on skeletal muscle phenotype in both young (day 60) and mature (day 120) lambs. Expression of myosin heavy chain (MyHC) isoforms were measured in Longissimus dorsi (LD), Semitendinosus (ST) and Supraspinatus (SS) muscles as markers of fibre type and metabolic enzyme activities were measured in LD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!